Jacobs & CO Regeneron Pharmaceuticals, Inc. Transaction History

Jacobs & CO

$1 Billion
Q3 2024

A detailed history of Jacobs & CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Jacobs & CO holds 9,127 shares of REGN stock, worth $6.75 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares

9,127

Previous 9,417 3.08%

Holding current value

$6.75 Million

Previous $9.9 Million 3.06%

% of portfolio

0.96%

Previous 1.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 01, 2024	SELL	$1024.09 - $1201.76 $296,986 - $348,510	-290 Reduced 3.08%	9,127 $9.59 Million
Q2 2024 Jul 12, 2024	SELL	$883.2 - $1071.19 $52,108 - $63,200	-59 Reduced 0.62%	9,417 $9.9 Million
Q1 2024 Apr 12, 2024	SELL	$902.69 - $993.35 $40,621 - $44,700	-45 Reduced 0.47%	9,476 $9.12 Million
Q4 2023 Jan 17, 2024	SELL	$775.18 - $881.7 $124,803 - $141,953	-161 Reduced 1.66%	9,521 $8.36 Million
Q3 2023 Oct 13, 2023	SELL	$692.45 - $844.37 $186,961 - $227,979	-270 Reduced 2.71%	9,682 $7.97 Million
Q2 2023 Jul 11, 2023	SELL	$700.03 - $830.35 $206,508 - $244,953	-295 Reduced 2.88%	9,952 $7.15 Million
Q1 2023 Apr 17, 2023	SELL	$680.49 - $826.97 $693,419 - $842,682	-1,019 Reduced 9.04%	10,247 $8.42 Million
Q4 2022 Jan 13, 2023	SELL	$705.89 - $766.39 $293,650 - $318,818	-416 Reduced 3.56%	11,266 $8.13 Million
Q3 2022 Oct 11, 2022	BUY	$573.97 - $724.32 $61,988 - $78,226	108 Added 0.93%	11,682 $8.05 Million
Q2 2022 Jul 19, 2022	SELL	$548.35 - $738.84 $382,199 - $514,971	-697 Reduced 5.68%	11,574 $6.84 Million
Q1 2022 Apr 14, 2022	SELL	$595.12 - $698.43 $249,355 - $292,642	-419 Reduced 3.3%	12,271 $8.57 Million
Q4 2021 Jan 21, 2022	BUY	$543.48 - $670.97 $185,326 - $228,800	341 Added 2.76%	12,690 $8.01 Million
Q3 2021 Oct 13, 2021	BUY	$574.03 - $680.96 $97,011 - $115,082	169 Added 1.39%	12,349 $7.47 Million
Q2 2021 Jul 15, 2021	BUY	$472.8 - $558.54 $68,556 - $80,988	145 Added 1.2%	12,180 $6.8 Million
Q1 2021 Apr 05, 2021	BUY	$446.73 - $548.2 $525,801 - $645,231	1,177 Added 10.84%	12,035 $5.69 Million
Q4 2020 Jan 12, 2021	BUY	$478.3 - $607.98 $837,025 - $1.06 Million	1,750 Added 19.21%	10,858 $5.25 Million
Q3 2020 Dec 03, 2020	BUY	$544.75 - $658.21 $2.34 Million - $2.83 Million	4,304 Added 89.59%	9,108 $5.1 Million
Q2 2020 Jul 09, 2020	SELL	$493.32 - $643.92 $572,251 - $746,947	-1,160 Reduced 19.45%	4,804 $3 Million
Q1 2020 Apr 13, 2020	BUY	$336.18 - $494.43 $2 Million - $2.95 Million	5,964 New	5,964 $2.91 Million
Q1 2018 Apr 30, 2018	SELL	$315.82 - $393.78 $9.97 Million - $12.4 Million	-31,557 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$358.63 - $469.95 $1.4 Million - $1.83 Million	-3,900 Reduced 11.0%	31,557 $996,000
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $15.3 Million - $17.9 Million	35,457	35,457 $1.13 Million

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs & CO with notifications on news.

Account